Millennium Management’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-42,074
Closed -$188K 6810
2023
Q4
$188K Sell
42,074
-154,239
-79% -$531K ﹤0.01% 5195
2023
Q3
$293K Buy
196,313
+103,666
+112% +$197K ﹤0.01% 4943
2023
Q2
$211K Sell
92,647
-158,848
-63% -$365K ﹤0.01% 5086
2023
Q1
$490K Sell
251,495
-69,023
-22% -$143K ﹤0.01% 4613
2022
Q4
$526K Buy
320,518
+110,128
+52% +$172K ﹤0.01% 4712
2022
Q3
$419K Buy
210,390
+97,189
+86% +$232K ﹤0.01% 5114
2022
Q2
$245K Sell
113,201
-74,117
-40% -$252K ﹤0.01% 5526
2022
Q1
$695K Sell
187,318
-108,521
-37% -$448K ﹤0.01% 4864
2021
Q4
$1.82M Buy
+295,839
New +$3.38M ﹤0.01% 3865

Other funds holding LIAN

Millennium Management's LIAN Position: Q1 2024 in Review

Millennium Management sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 42,074 shares — an estimated $188K sold.

Millennium Management first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $1.82M in Q4 2021. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

  • Millennium Management reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 42,074 LianBio American Depositary Shares shares in Q1 2024, an estimated $188K.
  • Millennium Management first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
  • Millennium Management's LianBio American Depositary Shares position peaked at $1.82M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.